Phase II study of osimertinib in NSCLC patients with EGFR exon 20 insertion mutation: A multicenter trial of the Korean Cancer Study Group (LU17-19)

Annals of Oncology ◽

10.1093/annonc/mdz260.051 ◽

2019 ◽

Vol 30 ◽

pp. v628

Author(s):

T.M. Kim ◽

C.-Y. Ock ◽

M. Kim ◽

S.H. Kim ◽

B. Keam ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Multicenter Trial ◽

Insertion Mutation ◽

Study Group ◽

Cancer Study ◽

Cancer Study Group ◽

Exon 20 ◽

Nsclc Patients

Download Full-text

Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study Group

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-018-2752-z ◽

2018 ◽

Vol 145 (3) ◽

pp. 717-723 ◽

Cited By ~ 16

Author(s):

Martin Fenner ◽

Christoph Oing ◽

Annette Dieing ◽

Thomas Gauler ◽

Karin Oechsle ◽

...

Keyword(s):

Testicular Cancer ◽

Germ Cell ◽

Phase Ii ◽

Germ Cell Tumors ◽

Multicenter Trial ◽

Study Group ◽

Open Label ◽

Cancer Study ◽

Cancer Study Group

Download Full-text

A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-012-1956-1 ◽

2012 ◽

Vol 70 (5) ◽

pp. 665-672 ◽

Cited By ~ 4

Author(s):

Yoon Hee Choi ◽

Sang Cheul Oh ◽

Jun Suk Kim ◽

Seung-Hyun Nam ◽

Bong-Seog Kim ◽

...

Keyword(s):

Gastric Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Adjuvant Treatment ◽

Phase Ii Study ◽

Study Group ◽

Cancer Study ◽

Cancer Study Group ◽

Recurrent Gastric Cancer ◽

Gastric Cancer Patients

Download Full-text

A phase II study of diaziquone in children with recurrent or progressive primary brain tumors: A report from the Childrens Cancer Study Group

Journal of Neuro-Oncology ◽

10.1007/bf00167071 ◽

1990 ◽

Vol 9 (1) ◽

pp. 69-76 ◽

Cited By ~ 13

Author(s):

Lawrence J. Ettinger ◽

Ning Ru ◽

Mark Krailo ◽

Kathleen S. Ruccione ◽

William Krivit ◽

...

Keyword(s):

Brain Tumors ◽

Phase Ii ◽

Phase Ii Study ◽

Study Group ◽

Cancer Study ◽

Primary Brain Tumors ◽

Cancer Study Group

Download Full-text

Safety, tolerability and activity of gefitinib (ZD1839) in combination with tamoxifen in ovarian cancer patients refractory to platinum-taxane based therapy – a Phase-II study of the Ovarian Cancer Study Group (AGO Ovar 2.6)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.5016 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 5016-5016

Author(s):

S. Loibl ◽

A. Du Bois ◽

J. Pfisterer ◽

J. Huober ◽

H.-J. Lueck ◽

...

Keyword(s):

Ovarian Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Study Group ◽

Cancer Study ◽

Cancer Study Group

Download Full-text

Concurrent cetuximab and radiotherapy after docetaxel–cisplatin induction chemotherapy in stage III NSCLC: Satellite—A phase II study from the Swedish Lung Cancer Study Group

Lung Cancer ◽

10.1016/j.lungcan.2010.05.011 ◽

2011 ◽

Vol 71 (2) ◽

pp. 166-172 ◽

Cited By ~ 33

Author(s):

A. Hallqvist ◽

G. Wagenius ◽

H. Rylander ◽

O. Brodin ◽

E. Holmberg ◽

...

Keyword(s):

Lung Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Phase Ii Study ◽

Stage Iii ◽

Study Group ◽

Cancer Study ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Stage Iii Nsclc

Download Full-text

Phase II Trial of Nilotinib in Patients With Metastatic Malignant Melanoma Harboring KIT Gene Aberration: A Multicenter Trial of Korean Cancer Study Group (UN10‐06)

The Oncologist ◽

10.1634/theoncologist.2015-0161 ◽

2015 ◽

Vol 20 (11) ◽

pp. 1312-1319 ◽

Cited By ~ 30

Author(s):

Su Jin Lee ◽

Tae Min Kim ◽

Yu Jung Kim ◽

Kee‐Taek Jang ◽

Hyo Jin Lee ◽

...

Keyword(s):

Malignant Melanoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Malignant Melanoma ◽

Multicenter Trial ◽

Study Group ◽

Cancer Study ◽

Cancer Study Group ◽

Kit Gene

Download Full-text

Phase II study of oxaliplatin, irinotecan and S-1 therapy in patients with advanced gastric cancer: the Korean Cancer Study Group ST14-11

Gastric Cancer ◽

10.1007/s10120-018-0794-1 ◽

2018 ◽

Vol 21 (5) ◽

pp. 802-810 ◽

Cited By ~ 3

Author(s):

Hyeong Su Kim ◽

Min-Hee Ryu ◽

Dae Young Zang ◽

Sook Ryun Park ◽

Boram Han ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Study Group ◽

Cancer Study ◽

Cancer Study Group

Download Full-text

Phase II Study of Oral S-1 Plus Irinotecan in Patients with Advanced Colorectal Cancer: Hokkaido Gastrointestinal Cancer Study Group HGCSG0302

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyi025 ◽

2005 ◽

Vol 35 (2) ◽

pp. 88-89 ◽

Cited By ~ 4

Author(s):

Y. Komatsu

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Gastrointestinal Cancer ◽

Advanced Colorectal Cancer ◽

Phase Ii Study ◽

Study Group ◽

Cancer Study ◽

Cancer Study Group

Download Full-text

A phase II study of irinotecan in children with relapsed or refractory neuroblastoma: A European cooperation of the Société Française d’Oncologie Pédiatrique (SFOP) and the United Kingdom Children Cancer Study Group (UKCCSG)

European Journal of Cancer ◽

10.1016/j.ejca.2008.08.003 ◽

2008 ◽

Vol 44 (16) ◽

pp. 2453-2460 ◽

Cited By ~ 28

Author(s):

Gilles Vassal ◽

Francesco Giammarile ◽

Mariel Brooks ◽

Birgit Geoerger ◽

Dominique Couanet ◽

...

Keyword(s):

United Kingdom ◽

Phase Ii ◽

Phase Ii Study ◽

Study Group ◽

Cancer Study ◽

European Cooperation ◽

The United Kingdom ◽

Cancer Study Group

Download Full-text

Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group

British Journal of Cancer ◽

10.1038/sj.bjc.66000524 ◽

2002 ◽

Vol 87 (7) ◽

pp. 729-732 ◽

Cited By ~ 24

Author(s):

C Kollmannsberger ◽

O Rick ◽

H Klaproth ◽

T Kubin ◽

H G Sayer ◽

...

Keyword(s):

Testicular Cancer ◽

Germ Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Cancer ◽

Germ Cell Cancer ◽

Study Group ◽

Cancer Study ◽

Cancer Study Group

Download Full-text